Abstract
Selective mutism is a multidimensional childhood disorder in which, according to the most recent studies, biologically mediated temperament and anxiety components seem to play a major role. Several psychotherapy methods have been reported in case studies to be useful, but the disorder is commonly seen to be resistant to change, particularly in cases of long duration. Currently, behaviour modification and other cognitive methods, together with cooperation with the family and the school personnel, are recommended in the treatment of selective mutism. Selective serotonin reuptake inhibitors and selective monoamine oxidase inhibitors have also been reported to be helpful when treating children with selective mutism. At the moment, pharmacotherapy cannot be recommended as the treatment of first choice but if other methods of treatment are not helpful, medication can be included in the treatment scheme. Comprehensive evaluation and treatment of possible primary and comorbid problems that require treatment are also essential.
Similar content being viewed by others
References
American Psychiatric Association. Diagnosis and statistical manual of mental disorders. 4th ed. Washington,DC: American Psychiatric Association, 1994
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992
Black B, Uhde T. Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry 1995; 34: 847–56
Kumpulainen K, Räsänen E, Raaska H, et al. Selective mutism among second-graders in elementary school. Eur Child Adolesc Psychiatry 1998; 7: 24–9
Dummit ES, Klein RG, Tancer NK, et al. Systematic assessment of 50 children with selective mutism. J Am Acad Child Adolesc Psychiatry 1997; 35: 653–60
Velting ON, Albano AM. Current trends in the understanding and treatment of social phobia in youth. J Child Psychol Psychiatry 2001; 42: 127–40
Kristensen H. Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 249–56
Crumley FE. The masquerade of mutism. J Am Acad Child Adolesc Psychiatry 1990; 29(2): 318–9
Jacobsen T. Case study: is selective mutism a manifestation of dissociative identity disorder? J Am Acad Child Adolesc Psychiatry 1995; 34: 863–6
Eldar S, Bleich A, Apter A, et al. Elective mutism — an atypical antecedent of schizophrenia. J Adolesc 1985; 8(3): 289–92
Gillberg IC, Gillberg C. Asperger syndrome — some epidemiological considerations: a research note. J Child Psychol Psychiatry 1989; 30: 631–8
Dow SP, Sonies BC, Scheib D, et al. Practical guidelines for the assessment and treatment of selective mutism. J Am Acad Child Adolesc Psychiatry 1995; 34: 836–46
Brown JB, Lloyd H. A controlled study of children not speaking at school. J Assoc Workers Maladjusted Child 1975; 3: 49–63
Fundudis T, Kolvin I, Garside RF. Speech retarded and deaf children: their psychological development. London: Academic Press, 1979
Kopp S, Gillberg C. Selective mutism: a population study. A research note. J Child Psychol Psychiatry 1997; 38: 257–62
Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994; 33: 1000–6
Krohn DD, Weckstein SM, Wright HL. A study of the effectiveness of a specific treatment for elective mutism. J Am Acad Child Adolesc Psychiatry 1992; 31(4): 711–8
Wergeland H. Elective mutism. Acta Psychiatr Scand 1979; 59: 218–28
Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 1992; 31: 1090–4
Kolvin I, Fundudis T. Elective mute children: psychological development and background factors. J Child Psychol Psychiatry 1981; 22: 219–32
Wilkins R. A comparison of elective mutism and emotional disorders in children. Br J Psychiatry 1985; 146: 198–203
Amari A, Slifer KJ, Gerson AC, et al. Treating selective mutism in a paediatric rehabilitation patient by altering environmental reinforcement contingencies. Pediatr Rehabil 1999; 3(2): 59–64
Rye MS, Ullman D. The successful treatment of long-term selective mutism: a case study. JBehav TherExp Psychiatry 1999; 30: 313–23
Goll K. Role structure and subculture in families of elective mutists. Fam Process 1979; 18: 55–68
Carlson JS, Kratochwill TR, Johnston H. Prevalence and treatment of selective mutism in clinical practice: a survey of child and adolescent psychiatrists. J Child Adolesc Psychopharmacol 1994; 4: 281–91
Joseph PR. Selective mutism — the child who doesn’t speak at school. Pediatrics 1999 Aug; 104 (2 Pt 1): 308–9
Anstendig KD. Is selective mutism an anxiety disorder? Rethinking its DSM-IV classification. J Anxiety Disord 1999; 13: 417–34
Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry 2002; 42: 73–90
Golwyn DH, Weinstock RC. Phenelzine treatment of elective mutism: a case report. J Clin Psychiatry 1990; 51: 384–5
Golwyn DH, Selvie CP. Phenelzine treatment of selective mutism in four prepubertal children. J Child Adolesc Psychopharmacol 1999; 9: 109–13
Wright HH, Cuccaro ML, Leonhardt TV, et al. Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism. J Am Acad Child Adolesc Psychiatry 1995; 32: 857–62
Dummit ES, Klein RG, Tancer NK, et al. Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 1996; 35: 615–21
Russell PS, Raj SE, John JK. Multimodal intervention for selective mutism in mentally retarded children. J Am Acad Child Adolesc Psychiatry 1998; 37(9): 903–4
Lafferty JE, Constantino JN. Fluvoxamine in selective mutism. J Am Acad Child Adolesc Psychiatry 1998; 37: 12–3
Rupp SN. Haloperidol for Tourette’s disorder plus selective mutism [letter]. J Am Acad Child Adolesc Psychiatry 1999; 38:7
Walkup J, Labellarte M. Complications of SSRI treatment. J Child Adolesc Psychopharmacol 2001; 11: 1–4
Carlson JS, Kratochwill TR, Hohnston HF. Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial. J Child Adolesc Psychopharmacol 1999; 9: 293–306
Acknowledgements
The author has no conflicts of interest that are directly relevant to the contents of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumpulainen, K. Phenomenology and Treatment of Selective Mutism. Mol Diag Ther 16, 175–180 (2002). https://doi.org/10.2165/00023210-200216030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200216030-00004